Search Results

Displaying Results 351-375 of 389 "'IO'"

Oct 21, 2025, 09:00 ET Damon Announces Full Technical Specifications for HyperSport Race Electric Motorcycle Featuring AI-Enabled I/O Platform

content:https://www.prnewswire.com/news-releases/damon-announces-full-technical-specifications-for-hypersport-race-electric-motorcycle-featuring-ai-enabled-io-platform-302590032.html

More news about: DAMON Motors Inc.


Oct 20, 2025, 07:00 ET HanchorBio Showcases Pipeline Momentum with HCB101 and HCB301 Data Across Five Major Oncology Meetings in Q4 2025

of the first-in-human Phase 1 study of HCB101 in relapsed/refractory non-Hodgkin lymphoma ESMO Immuno-Oncology Congress (ESMO-IO), December 10-12, 2025– One abstract integrating the HCB101 monotherapy and combination data across multiple solid tumor indications

More news about: HanchorBio Inc.


Oct 19, 2025, 20:10 ET ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)

levels (DL1-6, 1-45 mg/kg); 72.2% remain on treatment. Heavily pretreated population: over 51% received prior immuno-oncology (IO) therapies. Median follow-up: only 1.9 months (range 0.1-6.7 months) at data cutoff.

More news about: CStone Pharmaceuticals


Oct 17, 2025, 08:00 ET Marengo Presents Initial Phase 2 Results Demonstrating Broad Single-Agent Activity of Invikafusp Alfa Across Multiple PD-1-Refractory or -Resistant Solid Tumors as a Late-Breaking Oral Presentation at ESMO 2025

company is also progressing a Phase 2 combination with Trodelvy® (TROP2-directed ADC) in TNBC and HR+/HER2– breast cancer to evaluate synergy in ADC and IO settings. Invikafusp alfa is a first-in-class, bispecific dual T-cell agonist designed to selectively activate and expand Vβ6/Vβ10

More news about: Marengo Therapeutics


Oct 16, 2025, 08:00 ET Sycomp Intelligent Data Storage Platform Integrated with New Google Cloud Z3 Virtual Machines

and integrated archiving. "Z3 VMs represent a massive leap for high-performance storage on Google Cloud. Customers can now slash IO access latency by up to 35 percent, translating directly into faster workloads and greater efficiency compared to previous-generation local SSDs," said

More news about: Sycomp


Oct 15, 2025, 10:41 ET IO Health™ Raises $2M Seed Round to Scale Real-time Quality Platform

About IO Health IO Health Technologies is a California-based health tech company redefining post-acute and home-based care through its Care Optimized™ platform. Built by home health veterans, IO Health overlays existing EMRs with

More news about: io Health


Oct 15, 2025, 10:00 ET Nikon Small World Honors 51st Annual Photomicrography Competition

University at StarkDepartment of Biological SciencesNorth Canton, Ohio, USAHook-like crochets on the larva of an Io (Automeris io) mothConfocal40X (Objective Lens Magnification) Michael Parra PuentesBogotá,

More news about: Nikon Instruments Inc.


Oct 15, 2025, 07:54 ET PwC Partners with Oracle to Reimagine Finance Processes with AI in Oracle Fusion Cloud ERP

financial controls, align financial and operational planning, and streamline global reporting. For example, PwC is using Oracle Cloud ERP's document IO agent and AI-powered narrative reporting capabilities to automate document handling across end-to-end financial processes to further accelerate financial

More news about: Oracle


Oct 14, 2025, 09:01 ET d-Matrix Announces SquadRack, Industry's First Rack-Scale Solution Purpose-Built for AI Inference at Datacenter Scale

Accelerators with innovative compute-memory integration delivering ultra-low latency, high-throughput inference  d-Matrix JetStream™ IO Accelerators enabling ultra-low latency device-initiated, accelerator-to-accelerator communication using standard ethernet  Supermicro

More news about: d-Matrix


Oct 14, 2025, 09:00 ET Lunit AI Predicts Immunotherapy Outcome in Colorectal, Kidney, and Lung Cancer at ESMO 2025

SCOPE IO as a predictive biomarker for immunotherapy benefit in NSCLC. "At ESMO 2025, we are demonstrating how AI can unlock predictive biomarkers directly from routine pathology slides," said Brandon Suh, CEO of Lunit. "These findings show the potential of Lunit SCOPE IO to help

More news about: Lunit


Oct 14, 2025, 08:30 ET OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care

approximately 1.09 million new shares. "The acquisition of Woori IO delivers significant upside for OSRH shareholders," said Peter Hwang, CEO of OSRH. "Acquired at a valuation of less than $11 million, Woori IO is an undervalued opportunity compared with multi-billion-dollar continuous glucose

More news about: OSR Holdings


Oct 08, 2025, 08:00 ET Biond Biologics Announces Initiation of a Phase 2 Study of BND-22 in Combination with anti-PD-1 therapy

BND-22 (SAR444881) in combination with anti-PD-1 therapy in patients with locally advanced or metastatic NSCLC previously treated with immune-oncology (IO) therapies, and anti–PD-1/PD-L1 naïve patients with MSS-CRC or ovarian cancer (ClinicalTrials.gov Identifier: NCT06651593). The

More news about: Biond Biologics Ltd.


Oct 07, 2025, 09:00 ET Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion

deployment, clinical-stage immunotherapy developers including GT Biopharma, Inc. (NASDAQ: GTBP), Leap Therapeutics, Inc. (NASDAQ: LPTX), IO Biotech (NASDAQ: IOBT), Celcuity Inc. (NASDAQ: CELC), and MAIA Biotechnology, Inc. (NYSE-American: MAIA).

More news about: USA News Group


Oct 02, 2025, 08:08 ET Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775

advanced/recurrent endometrial cancer(aEC) that progressed on platinum-basedchemotherapy (PBC) and an anti-PD-(L)1immunotherapy (IO)

More news about: Eisai Inc.


Oct 02, 2025, 08:04 ET OpenAP Expands Video Scale, Driving Audience Standardization Across the Largest Footprint of Premium Video

advertisers to easily distribute audiences across every premium video destination while offering the flexibility to activate through direct insertion order (IO), programmatic guaranteed (PG) or private marketplace (PMP) deals. Powered by best-in-market data integrations, a multi-source identity framework and

More news about: OpenAP


Sep 30, 2025, 09:07 ET SPAYZ.io White Paper Explores Opportunities, Challenges and Ambitions in Payments Industry

https://mma.prnewswire.com/media/2785841/SPAYZ_io_Photo.jpg Logo - https://mma.prnewswire.com/media/2785840/SPAYZ_io_Logo.jpg 

More news about: SPAYZ.io


Sep 30, 2025, 09:00 ET Damon Provides Operational Business Update and Reports Fiscal Year 2025 Results

of the HyperSport Race program and its associated benefits, the Company's expectations for the prospects of the evolving Damon IO system and the integration of the Damon IO platform with the Company's hardware design, the Company's asset-light business model and planned revenue verticals and other expected

More news about: DAMON Motors Inc.


Sep 30, 2025, 08:00 ET Immuno-Oncology 360º Announces 2026 Featured Speakers and Key Topics for the 12th Annual Meeting in Boston

"IO360º provides curated content on the most pertinent scientific and clinical advances in IO paired with business and market insights highlighting critical trends and directions of the field, in a unique blend that makes this event deeply insightful and predictive of the future of IO," said Dr

More news about: Immuno-Oncology 360º


Sep 29, 2025, 04:08 ET Introducing the Sailing Lantern

has studios in San Francisco and London. LoveFrom was founded by Sir Jony Ive, who led design at Apple for nearly three decades. Jony also co-founded io Products, Inc in 2024, now part of OpenAI.lovefrom.com

More news about: BALMUDA


Sep 29, 2025, 04:08 ET Introducing the Sailing Lantern

has studios in San Francisco and London. LoveFrom was founded by Sir Jony Ive, who led design at Apple for nearly three decades. Jony also co-founded io Products, Inc in 2024, now part of OpenAI.lovefrom.com

More news about: BALMUDA


Sep 25, 2025, 11:00 ET Ultra Pure Sharpens Q4 Strategy to Align with Consumer Preferences and Holiday Demand

https://www.youtube.com/watch?v=Io1IAvHVQ_M Check out the NPR planet Money Episode 826 "The Vodka Proof"

More news about: Ultra Pure, LLC


Sep 24, 2025, 16:00 ET Synopsys Collaborates with TSMC to Drive the Next Wave of AI and Multi-Die Innovation

applications. Synopsys provides a comprehensive suite of high-performance proven PHYs, embedded memories, high-density logic libraries, programmable IO, and NVM IP. With dedicated IP for N5A and N3A automotive nodes, along with advanced SRAM and Foundation IP for 5nm and 3nm SoCs, Synopsys empowers customers

More news about: Synopsys, Inc.


Sep 24, 2025, 09:00 ET Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials

Lunit, via AI analysis of H&E with its Lunit SCOPE IO® product. Each service aims to enable the use of quantitative immune phenotyping within clinical trials. One benefit of the partnership is access to Lunit SCOPE IO, within CellCarta's global, best-in-class clinical infrastructure

More news about: Lunit


Sep 24, 2025, 08:00 ET CodeSignal Expands Skills-Based Hiring Across Finance, Accounting, and Business Roles

Validated Skills Assessments: Role-specific assessments, developed by validated by Industrial-Organizational (IO) Psychologists and maintained by subject matter experts, measuring the competencies most critical for finance, accounting, and business analysis.

More news about: CodeSignal


Sep 23, 2025, 09:00 ET Damon Successfully Completes HyperSport Race Clay Modelling, Progressing Toward Combining Its AI-Enabled Platform with Advanced Hardware Design

the HyperSport Race program and its associated benefits, and the Company's expectations for the prospects of the evolving Damon IO system and the integration of the Damon IO platform with the Company's hardware design. Forward-looking statements are, by their nature, not guarantees of Damon's future operational

More news about: DAMON Motors Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.